Alcohol detox for Jupiter — CIWA-Ar-guided, medically supervised, discretion assured.

For families in Jupiter, RECO Island's Delray Beach campus is a 45-minute drive south on I-95 — close enough for weekly in-person family sessions from Abacoa or Tequesta, far enough for genuine separation from local triggers. Alcohol detox is physician-led with CIWA-Ar-scored, symptom-triggered benzodiazepine dosing, day-one parenteral thiamine, and 24/7 nursing. Clients transition directly in-house from detox to residential treatment under the same clinical team — no waitlist, no third-party handoff.

From Jupiter, the RECO Island campus in Delray Beach sits 32 miles south on I-95 — roughly 45 minutes outside of rush hour. For families in Abacoa, Tequesta, Admirals Cove, or Jupiter Inlet Colony, that distance keeps a spouse or adult child within same-day reach for family sessions while providing the geographic separation from the local bar, liquor store, and drinking network that supervised inpatient alcohol detox requires. Alcohol withdrawal is not a taper to attempt at home.

Alcohol withdrawal is the one that can kill

Among substance withdrawal syndromes, alcohol withdrawal is the one with genuine mortality. Opioid withdrawal is miserable but not lethal in an otherwise healthy adult; stimulant withdrawal is a psychiatric event rather than a medical one. Alcohol withdrawal produces seizures, delirium tremens, and cardiovascular instability, and mortality from untreated DTs remains in the low single-digit percent range even with modern supportive care. The ASAM Criteria classify moderate-to-severe alcohol withdrawal as Dimension 3 acuity — biomedical conditions and complications requiring medically managed inpatient care.

Risk stratification at admission drives everything that follows. The strongest predictor of a complicated withdrawal is a history of prior withdrawal seizures or DTs. Other established predictors include sustained daily consumption above roughly eight standard drinks over years, older age, poorly controlled hypertension, hepatic dysfunction, concurrent benzodiazepine dependence, and electrolyte derangement — particularly low magnesium and potassium. RECO Island’s intake H&P and admission labs (CBC, CMP, LFTs, GGT, magnesium, phosphate, lipase, urine drug screen, pregnancy testing when applicable) identify the high-risk client before the first CIWA-Ar score is recorded.

CIWA-Ar-guided, symptom-triggered benzodiazepine management

The Clinical Institute Withdrawal Assessment for Alcohol, revised, scores ten symptom domains: nausea and vomiting, tremor, paroxysmal sweats, anxiety, agitation, orientation, tactile disturbances, auditory disturbances, visual disturbances, and headache. Nurses reassess at defined intervals — every one to two hours during peak withdrawal, extending to every four hours as scores fall. Benzodiazepine dosing is triggered when scores cross the treatment threshold rather than administered on a fixed schedule.

Agent selection is clinical. Chlordiazepoxide is a workhorse long-acting agent that produces a smooth self-taper through active metabolites in clients with intact hepatic function. Diazepam offers a similar profile with faster onset. Lorazepam is preferred in advanced hepatic dysfunction, older adults, and any client whose oxidative metabolism cannot be trusted, because it clears through glucuronidation independent of CYP450 first-pass metabolism. Symptom-triggered protocols produce shorter treatment courses, lower cumulative benzodiazepine load, and fewer breakthrough seizures than fixed-schedule dosing across every published head-to-head comparison.

Thiamine, folate, and preventing Wernicke-Korsakoff

Chronic heavy alcohol use depletes thiamine through reduced dietary intake, impaired intestinal absorption, and diminished hepatic storage. Untreated deficiency produces Wernicke’s encephalopathy — the classic triad of ophthalmoplegia, ataxia, and altered mental status, though the full triad appears in fewer than one in five cases. Progression to Korsakoff’s syndrome causes an anterograde amnesia and confabulatory picture that does not reverse with later replacement. This is a preventable neurologic injury, and prevention costs less than a dollar per dose.

RECO Island’s admission protocol delivers 100 mg parenteral thiamine on day one — intramuscular or intravenous, given before any glucose-containing IV fluid, because carbohydrate loading in a thiamine-deficient patient can precipitate Wernicke’s. Folate 1 mg, a multivitamin, and magnesium replacement to correct the hypomagnesemia that accompanies chronic drinking follow. Oral thiamine continues through the residential stay. Clients with clinical features suggesting active Wernicke’s receive higher-dose parenteral thiamine (500 mg IV three times daily) per current evidence.

MAT decisions during detox and the transition to residential

Detox is medical stabilization, not treatment for alcohol use disorder. The treatment is what happens next. RECO Island’s model transitions clients directly in-house from detox to residential — same clinical team, same physicians, no handoff to an outside facility, no waitlist. Because the transition is internal, medication-assisted treatment for alcohol use disorder is discussed and often initiated during the detox stay rather than deferred to a future intake somewhere else.

Three FDA-approved medications carry the strongest evidence. Naltrexone (oral 50 mg daily, or long-acting injectable Vivitrol 380 mg intramuscular every four weeks) blunts the reinforcing pull of alcohol and requires a 7-10 day opioid-free window that detox reliably provides. Acamprosate reduces protracted withdrawal-driven craving and is initiated after abstinence is stabilized. Disulfiram produces the acetaldehyde reaction that punishes any drinking and is appropriate for a motivated subset with the right support structure. The medication decision is folded into the treatment plan alongside the CBT, motivational interviewing, and relapse-prevention work that residential care delivers.

What the first 72 hours look like

Peak alcohol withdrawal falls between 24 and 72 hours after the last drink. Autonomic symptoms — tachycardia, hypertension, tremor, diaphoresis — appear first, often within 6-12 hours. Withdrawal seizures, when they occur, cluster in the 12-48 hour window. Delirium tremens characteristically emerges later, at 48-96 hours, which is why nursing coverage does not thin out on day three. Clients are monitored around the clock through this window with vital signs, CIWA-Ar scoring, and daily physician review — more often for higher-acuity presentations.

Alongside the withdrawal protocol, the clinical team begins the psychiatric assessment that shapes residential treatment planning. Alcohol use disorder is comorbid with major depressive disorder, generalized anxiety, PTSD, and bipolar spectrum illness at rates that make screening non-optional. PHQ-9, GAD-7, PCL-5, and MDQ scores collected during the detox stay — with the caveat that acute withdrawal inflates depression and anxiety scores — feed into a psychiatric evaluation that is reassessed at day 7-14 once withdrawal has resolved and any indicated pharmacotherapy (sertraline, buspirone, quetiapine, or others) is considered on a clean baseline.

Insurance and admissions from Jupiter

RECO Island is in-network with Florida Blue, Aetna, Cigna, UnitedHealthcare, Humana, and BCBS plans. Verification of benefits — deductible, coinsurance, out-of-pocket maximum, and any prior authorization requirement — is typically completed within an hour for commercial policies, so families know the coverage picture before the drive south. The route is straightforward: I-95 south to exit 52 (Atlantic Avenue) in Delray Beach. Admissions coordinators handle the intake call, benefits check, and clinical pre-screen before the client leaves Jupiter, and the campus is set up for discreet direct arrival rather than a lobby wait.

Serving residents of: Abacoa, Jupiter Inlet Colony, Tequesta, Admirals Cove, Jonathan's Landing.